Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu‐Pei Chen, Jun Ma, Xiaomin Li et al.|Cell Research|2020Cited by 483
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatmentJia‐Wei Lv, Jun Ma, Wei Yuan et al.|Nature Medicine|2023Cited by 104
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu‐Pei Chen, Jun Ma, Jia‐Wei Lv et al.|Molecular Cancer|2021Cited by 99
miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathwaysQing‐Mei He, Na Liu|Oncotarget|2015Cited by 57